HUNILIFE BIOTECHNOLOGY
HuniLife Biotechnology provides antibodies and novel chemotherapy drugs for the treatment of cancer and immune diseases. The company's strategy is to focus on the early-stage research and development of drugs and various preclinical experiments and to promote the research and development of products in human clinical trials
HUNILIFE BIOTECHNOLOGY
Industry:
Biotechnology Consumer Research Health Care Pharmaceutical
Founded:
2013-12-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.hunilife.com
Total Employee:
11+
Status:
Active
Contact:
+886 02 2657 9668
Email Addresses:
[email protected]
Official Site Inspections
http://www.hunilife.com
- Host name: 172-237-5-207.ip.linodeusercontent.com
- IP address: 172.237.5.207
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HuniLife Biotechnology"
HuniLife Biotechnology, Inc.
Aug 19, 2024 HuniLife Biotechnology , Inc. was established in December 2013 and is headquartered in Neihu Science Park, Taipei City. It is a biopharmaceutical company focusing …See details»
上毅生物科技股份有限公司
上毅生物科技股份有限公司成立於2013年12月，總部設於台北市內湖科學園區，是以新藥開發為主軸的生技製藥公司，開發具有世界專利保護及市場競爭優勢的藥物，治療性抗體及新穎化療藥 …See details»
HuniLife Biotechnology - Crunchbase Company Profile & Funding
Organization. HuniLife Biotechnology . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. HuniLife Biotechnology is a paramedical research …See details»
Hunilife Biotechnology, Inc. (上毅生物科技股份有限公司) - 药物管 …
了解Hunilife Biotechnology, Inc. (上毅生物科技股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的1项临床试和4篇文献，疾病领域:内分泌与代谢疾病，血液及淋巴系统疾病，免 …See details»
HuniLife Biotechnology - Overview, News & Similar companies
HuniLife strives to develop efficacious therapeutics for the treatment of human diseases while aiming to bring long lasting value to our shareholde rs. We are now developing new generation …See details»
HuniLife Biotechnology - Company Profile - Tracxn
Nov 27, 2024 Hunilife has received exclusive development rights of the ENO1 antibody from National Health Research Institute and Development Center for Biotechnology in Taiwan. …See details»
HuniLife Biotechnology - Craft
HuniLife Biotechnology Summary. Company Summary. Overview. HuniLife Biotechnology is a biopharmaceutical company engaged in drug development. It offers humanized monoclonal …See details»
HuniLife Biotechnology Inc. and Shimadzu Corporation signed a ...
HuniLife Biotechnology, Inc., was established in December 2013, headquartered in Neihu Sciences Park, Taipei City, Taiwan. HuniLife focuses on the new drug development for the …See details»
Contact Us - HuniLife Biotechnology, Inc.
HuniLife Biotechnology, Inc., was established in December 2013, headquartered in Neihu Sciences Park, Taipei City, Taiwan. HuniLife focuses on the new drug development for the …See details»
About | HuniLife Biotechnology, Inc. - 上毅生物科技股份有限公司
HuniLife Biotechnology , Inc. was established in December 2013 and is headquartered in Neihu Science Park, Taipei City. It is a biopharmaceutical company focusing on the development of …See details»
HuniLife Biotechnology - Tech Stack, Apps, Patents & Trademarks
HuniLife Biotechnology is a paramedical research center. Start Free Trial . Chrome ExtensionSee details»
HuniLife Biotechnology Inc. has licensed“ENO1 monoclonal …
Dec 15, 2015 HuniLife believes that the novel HuL001 has a wide range of clinical application including multiple sclerosis and cancer. HuniLife Biotechnology, Inc., was established in …See details»
HuL-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 29, 2024 A Phase 1 Single and Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 in Healthy Volunteers and Idiopathic …See details»
HuL001 in Idiopathic Pulmonary Fibrosis - ICH GCP
Aug 25, 2020 HuniLife Biotechnology, Inc. Investigators. Principal Investigator: Hao-Chien Wang, MD, National Taiwan University Hospital Study record dates. These dates track the …See details»
Partner | HuniLife Biotechnology, Inc.
HuniLife Biotechnology works with excellent partners, and together we are continuing original research and development. The National Health Research Institutes (NHRI) is a non-profit …See details»
Monoclonal enolase-1 blocking antibody ameliorates pulmonary ...
Nov 14, 2023 4 Department of Research and Development, HuniLife Biotechnology Inc, Rm. 1, 6F., No. 308, Sec. 1, Neihu Rd., Neihu Dist, 114, Taipei City, Taiwan. [email protected]. …See details»
Research and Development-HuniLife Biotechnology, Inc.
HuniLife is committed to developing first-in-class therapeutics for unmet medical need, indicating the innovation-pursuing nature of HuniLife. The products in development at HuniLife are …See details»
Carfilzomib nanoparticle - HunLife Biotechnology - AdisInsight
Oct 28, 2024 Carfilzomib as a lactosome nanoparticle formulation (designated as HuL 002) is being developed by HuniLife Biotechnology for the treatment of multiple myeloma. Carfilzomib …See details»
HuniLife Biotech Announces Abstract Accepted for Oral ... - BioSpace
Sep 9, 2024 HuniLife Biotech is pioneering in the clinical development of first-in-class therapeutics to reprogram the immunometabolism of tumor microenvironment in cancer. …See details»
Monoclonal enolase-1 blocking antibody ameliorates pulmonary
From European Pharmacopoeia. HuniLife’s proprietary ENO1 monoclonal antibody (Ab) HL217 was described previously (as HuL227) for its pre-clinical investigation in prostate cancer [14]. …See details»